| |
 Camillo
Ricordi, MD
cricordi@mednet.med.miami.edu
Camillo Ricordi, M.D., concluded his graduate/post-graduate studies
and his
surgical residency with the highest scores and honors in his native
Italy. In
September 1996, he assumed the position of Scientific Director and
Chief
Academic Officer of the Diabetes Research Institute. Dr. Ricordi
is the first
Stacy Joy Goodman Professor of Surgery and Medicine and the current
Chief
of the Division of Cellular Transplantation at the University of
Miami School of
Medicine.
Prior to joining the DRI, Dr. Ricordi served as Attending Surgeon
at the San Raffaele Institute, University of
Milan School of Medicine (1988-1989). He then spent four years as
Associate Professor of Surgery and
Director of Cellular Transplantation at the University of Pittsburgh
Transplantation Institute (1989-1993) before
coming to Miami.
Acknowledged by his peers as one of the world's leading scientists
in islet transplantation, Dr. Ricordi has
trained the majority of islet cell transplant researchers worldwide
and has developed highly innovative
strategies in an attempt to transplant islets without the continuous
requirement for immunosuppressive drugs.
Dr. Ricordi is well-known for inventing the machine that made it
possible to isolate large numbers of islet cells
from the human pancreas and his procedure, the Ricordi method, is
in use worldwide by centers performing
clinical islet transplants.
Dr. Ricordi is founder and past president of the Cell Transplant
Society, co-founder and steering committee
member of the International Association for Pancreas and Islet Transplantation
(IPITA), and co-founder of the
National Diabetes Research Coalition. Dr. Ricordi is also an active
member of The Transplantation Society,
the American Diabetes Association, the American Federation of Clinical
Research, and the American
Society of Transplant Surgeons. Additionally, Dr. Ricordi has been
a reviewer of application grants for a
number of organizations, including the European Economic Community,
National Institutes of Health,
Canadian Diabetes Association, and the Juvenile Diabetes Foundation.
Dr. Ricordi has received numerous honors and awards, including
the 1987-88 National Research Service
Award (U.S.A.) in Immunogenetics and Immunobiology of Islet Transplantation,
the 1991 Lilly Humulin Prize on
Isolation and Transplantation of Pancreatic Islets, as well as various
Research Grant Awards from the Juvenile
Diabetes Foundation International, American Diabetes Association
and National Institutes of Health. He was
Chairman of the First and Third International Congresses of the
Cell Transplant Society, Pittsburgh,
Pennsylvania (1992) and Miami, Florida (1996) and was Chairman of
the Fifth International Congress on
Pancreas and Islet Transplantation, Miami Beach, Florida (1995).
A member of the NIH-NIAID Expert Panel
on clinical approaches for tolerance induction, Dr. Ricordi was
an invited speaker to the Pig to Human
Transplantation Nobel Forum in Stockholm, Sweden. An editor of books
on cellular transplantation and a
reviewer of several diabetes, transplantation, and related journals,
Dr. Ricordi also has been serving on the
editorial boards of Transplantation, Cell Transplantation (Section
Editor), Graft (Co-Editor in Chief),
Transplantation Proceedings, and Tissue Engineering. Dr. Ricordi
has authored more than 260 scientific
publications.
|
